Truist Financial Lowers Humana (NYSE:HUM) Price Target to $200.00

Humana (NYSE:HUM) had its target price cut by Truist Financial from $285.00 to $200.00 in a research note issued to investors on Tuesday, MarketBeat reports. The firm currently has a “hold” rating on the insurance provider’s stock. Truist Financial’s price target suggests a potential upside of 6.66% from the stock’s current price.

HUM has been the topic of several other reports. JPMorgan Chase & Co. dropped their target price on Humana from $274.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, February 13th. UBS Group lowered their price target on Humana from $285.00 to $195.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. Zacks Research downgraded shares of Humana from a “hold” rating to a “strong sell” rating in a report on Thursday, January 1st. Evercore decreased their price objective on shares of Humana from $260.00 to $180.00 in a research report on Thursday, February 12th. Finally, Morgan Stanley set a $146.00 target price on shares of Humana in a research note on Thursday, February 12th. Seven investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $228.48.

Humana Stock Up 1.4%

NYSE:HUM opened at $187.52 on Tuesday. The company’s 50-day simple moving average is $240.52 and its 200-day simple moving average is $259.61. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.02 and a current ratio of 2.00. Humana has a fifty-two week low of $169.61 and a fifty-two week high of $315.35. The stock has a market capitalization of $22.55 billion, a P/E ratio of 19.10, a P/E/G ratio of 1.98 and a beta of 0.44.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. Humana’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts anticipate that Humana will post 16.47 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Revolve Wealth Partners LLC purchased a new position in shares of Humana during the 4th quarter valued at about $202,000. Woodline Partners LP grew its holdings in Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after acquiring an additional 8,372 shares during the period. Sivia Capital Partners LLC raised its position in Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after acquiring an additional 452 shares in the last quarter. Atria Wealth Solutions Inc. lifted its holdings in Humana by 10.3% in the second quarter. Atria Wealth Solutions Inc. now owns 955 shares of the insurance provider’s stock valued at $234,000 after acquiring an additional 89 shares during the period. Finally, Nordea Investment Management AB lifted its holdings in Humana by 5.2% in the second quarter. Nordea Investment Management AB now owns 10,222 shares of the insurance provider’s stock valued at $2,475,000 after acquiring an additional 507 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.